CD4 and neoplasm: It is possible that a similar phenomenon occurs in the tumor setting and in the background of LEC MHC-II−/−, in which antigen-loaded LECs modulates CD4+ T cells in the TME not through direct antigen presentation but through elaboration of soluble factors.